Sandoz Thailand is the local affiliate of Sandoz, a global leader in generics and biosimilars. The company is committed to improving patient access to high‑quality, affordable medicines across Thailand, supporting the sustainability of the healthcare system.
With a strong portfolio spanning generic medicines, biosimilars, and specialty products, Sandoz Thailand serves both public and private healthcare sectors, working closely with healthcare professionals, hospitals, and government stakeholders. The company adheres to the highest standards of quality, compliance, and pharmacovigilance, in line with global Sandoz and international regulatory requirements.
Sandoz Thailand plays an active role in advancing biosimilar adoption, fostering local partnerships, and contributing to long‑term healthcare value through innovation, operational excellence, and patient‑centric solutions.